MIRA INFORM REPORT
|
Report No. : |
326445 |
|
Report Date : |
16.07.2015 |
IDENTIFICATION DETAILS
|
Name : |
KARTAVYA HEALTHEON PRIVATE LIMITED (W.E.F. 18.03.2011) |
|
|
|
|
Formerly Known
As : |
KARTAVYA
BPO PRIVATE LIMITED |
|
|
|
|
Registered Office
: |
30-A, Khotachi Wadi, Girgaum, Mumbai – 400004, Maharashtra |
|
Tel. No.: |
91-22-61131431 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
02.07.2008 |
|
|
|
|
Com. Reg. No.: |
11-184213 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 0.114 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U74999MH2008PTC184213 |
|
|
|
|
IEC No.: |
0312035781 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMK18253E |
|
|
|
|
PAN No.: [Permanent Account No.] |
AADCK4268L |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in providing chronic disease management services. |
|
|
|
|
No. of Employees
: |
120 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (46) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company incorporated during the year 2008
having a satisfactory track record. Profit of the company has declined during FY 2014. However, reserves
position of the company is sound. General financial position of the company
is good. Further, the rating also takes into consideration favorable gap
between trade payable and trade receivable. Trade relations are reported as fair. Business is active. Payments
terms are reported to be usually correct. In view of acceptable financial base, the company can be considered
normal for business dealings at usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2013.
INFORMATION PARTED BY
|
Name : |
Mr. Anil Nayak |
|
Designation : |
Director |
|
Contact No.: |
91-9322332782 |
|
Date : |
13.07.2015 |
|
Name : |
Ms. Dipti Pimple |
|
Designation : |
Accounts Department |
|
Contact No.: |
91-22-61131414 |
|
Date : |
13.07.2015 |
LOCATIONS
|
Registered Office : |
30-A, Khotachi Wadi, Girgaum, Mumbai – 400004, Maharashtra, India |
|
Tel. No.: |
91-22-61131431 |
|
Mobile No.: |
91-9322332782 (Mr. Anil Nayak) |
|
Fax No.: |
91-22-61131428 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
4500 Sq. Ft. |
|
Location : |
Leased |
|
|
|
|
Branch Office : |
206, Shankar Complex, Above VLCC, G. S. Road, Christian Basti,
District Kamrup, Guwahati – 781005, Assam, India |
|
Tel. No.: |
91-361-2340203 |
|
Area : |
600 Sq. Ft. |
|
Location : |
Leased |
|
|
|
|
Corporate Office : |
514-519, Corporate Avenue, 5th Floor, Sonawala Lane,
Goregaon (East), Mumbai, Maharashtra, India |
|
Tel. No.: |
91-22- 61131400 / 61131431 |
|
|
|
|
Principal Place of Business / Mailing Address : |
412-413 Corporate Avenue, Nearr Udyog Bhawan, Sonawala Road, Goregaon (East), Mumbai – 400063, Maharashtra, India |
|
Tel. No.: |
91-22- 61131400 / 61131419 / 61131417 / 61131414 / 61131416 |
|
Fax No.: |
91-22-61131418 |
DIRECTORS
As on 25.08.2014
|
Name : |
Mr. Anil Nayak |
|
Designation : |
Director |
|
Address : |
12/14, New Quereshi Mahal, M. M. C. Road, Mahim (West), Mumbai, 400016 - Maharashtra, India |
|
Date of Birth/Age : |
07.09.1974 |
|
Qualification : |
PGDAC |
|
Experience : |
16 Years |
|
Date of Appointment : |
02.07.2008 |
|
PAN No.: |
ADGPN2714F |
|
DIN No.: |
02168730 |
|
|
|
|
Name : |
Mr. Bikram Binay Srivastava |
|
Designation : |
Director |
|
Address : |
30-A, Khotachi Wadi, Girgaum, Mumbai – 400004, Maharashtra, India |
|
Date of Birth/Age : |
07.07.1973 |
|
Qualification : |
MBA |
|
Experience : |
15 Years |
|
Date of Appointment : |
02.07.2008 |
|
PAN No.: |
AMZPS2779K |
|
DIN No.: |
02211157 |
KEY EXECUTIVES
|
Name : |
Ms. Dipti Pimple |
|
Designation : |
Accounts Department |
MAJOR SHAREHOLDERS
As on 25.08.2014
|
Names of Shareholders |
No. of Shares |
%age
holding |
|
Anil Nayak |
5700 |
50.00 |
|
Bikram Binay Srivastava |
5700 |
50.00 |
|
Total |
11400 |
100.00 |
As on 25.08.2014
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in providing chronic disease management services. |
|
|
|
|
Products : |
Not Available |
|
|
|
|
Brand Names : |
Not Available |
|
|
|
|
Agencies Held : |
Not Available |
|
|
|
|
Exports : |
Not Available |
|
|
|
|
Imports : |
Not Available |
|
|
|
|
Terms : |
|
|
Selling : |
Credit (30 Days) |
|
|
|
|
Purchasing : |
Credit (60 Days) |
PRODUCTION STATUS = NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
Pharma Companies
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
120 (Approximately) |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
Auditors 1 : |
|
|
Name : |
Garg and Associates Chartered Accountants |
|
Address : |
201, 2nd Floor, Dimple Arcade Building No. 10, Asha Nagar Kandivali
(East), Mumbai – 400101, Maharashtra, INDIA |
|
Tel. No.: |
91-22-32252257 |
|
E-Mail : |
|
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AAIFG7472Q |
|
|
|
|
Auditors 2 : |
|
|
Name : |
Amit Singh and Associates Chartered Accountants |
|
Address : |
C-310, Antop Hill Ware Housing Company Limited, V.I.T. College Road,
Wadala (East), Mumbai - 400037 |
|
Tel. No.: |
91-22-24166621 / 24165654 |
|
Mobile No.: |
91-9930141693 |
|
Fax No.: |
91-22-24134538 |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Sister Concern : |
Address : 520-523,
Corporate Avenue, Sonawala Lane, Goregaon East, Mumbai – 400063, Maharashtra,
India Line of Business
: Pathology Lab
Address : 511, Corporate
Avenue, Sonawala Lane, Goregaon East, Mumbai – 400063, Maharashtra, India Line of
Business: Supply Chain of Medicines. |
CAPITAL STRUCTURE
As on 31.03.2014
Authorised Capital:
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
100000 |
Equity Shares |
Rs.10/- each |
Rs.1.000 Million |
Issued, Subscribed & Paid-up Capital:
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
11400 |
Equity Shares |
Rs.10/- each |
Rs.0.114
Million |
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED BALANCE SHEET
|
SOURCES
OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
0.114 |
0.114 |
0.114 |
|
(b) Reserves & Surplus |
13.617 |
9.902 |
4.261 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
13.731 |
10.016 |
4.375 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
3.542 |
0.264 |
0.929 |
|
(b) Deferred tax liabilities
(Net) |
0.154 |
0.054 |
0.054 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
0.000 |
0.000 |
0.000 |
|
Total
Non-current Liabilities (3) |
3.696 |
0.318 |
0.983 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
4.236 |
0.000 |
0.000 |
|
(b) Trade payables |
2.149 |
0.429 |
0.197 |
|
(c) Other current liabilities |
7.359 |
3.732 |
2.559 |
|
(d) Short-term provisions |
1.137 |
1.880 |
0.833 |
|
Total
Current Liabilities (4) |
14.881 |
6.041 |
3.589 |
|
|
|
|
|
|
TOTAL |
32.308 |
16.375 |
8.947 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
1.620 |
1.591 |
1.558 |
|
(ii) Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv) Intangible assets under
development |
1.262 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.076 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
0.000 |
0.000 |
0.000 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
2.958 |
1.591 |
1.558 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
1.700 |
0.480 |
0.000 |
|
(c) Trade receivables |
12.684 |
9.908 |
1.937 |
|
(d) Cash and cash equivalents |
0.542 |
0.398 |
2.381 |
|
(e) Short-term loans and
advances |
1.998 |
0.610 |
0.555 |
|
(f) Other current assets |
12.426 |
3.388 |
2.516 |
|
Total
Current Assets |
29.350 |
14.784 |
7.389 |
|
|
|
|
|
|
TOTAL |
32.308 |
16.375 |
8.947 |
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
SALES |
|
|
|
|
|
Income |
46.626 |
34.856 |
23.292 |
|
|
Other Income |
0.137 |
0.000 |
0.052 |
|
|
TOTAL |
46.763 |
34.856 |
23.344 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Operative Expenses |
0.111 |
0.780 |
0.000 |
|
|
Employees benefits
expense |
21.653 |
15.977 |
11.982 |
|
|
Other expenses |
17.800 |
9.975 |
8.549 |
|
|
TOTAL |
39.564 |
26.732 |
20.531 |
|
|
|
|
|
|
|
Less |
PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND
AMORTISATION |
7.199 |
8.124 |
2.813 |
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES |
1.816 |
0.040 |
0.011 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
TAX, DEPRECIATION AND AMORTISATION |
5.383 |
8.084 |
2.802 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
0.432 |
0.563 |
0.173 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE TAX |
4.951 |
7.521 |
2.629 |
|
|
|
|
|
|
|
Less |
TAX |
1.236 |
1.880 |
0.008 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) AFTER TAX
|
3.715 |
5.641 |
2.621 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per Share
(Rs.) |
325.87 |
494.82 |
229.91 |
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash flows from |
NA |
NA |
NA |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin (PAT/Sales) |
(%) |
7.97 |
16.18 |
11.25 |
|
|
|
|
|
|
|
Operating Profit Margin (PBDIT / Sales) |
(%) |
15.44 |
23.31 |
12.08 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
15.99 |
45.93 |
29.38 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.36 |
0.75 |
0.60 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.57 |
0.03 |
0.21 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.97 |
2.45 |
2.06 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Share Capital |
0.114 |
0.114 |
0.114 |
|
Reserves & Surplus |
4.261 |
9.902 |
13.617 |
|
Net worth |
4.375 |
10.016 |
13.731 |
|
|
|
|
|
|
long-term borrowings |
0.929 |
0.264 |
3.542 |
|
Short term borrowings |
0.000 |
0.000 |
4.236 |
|
Total borrowings |
0.929 |
0.264 |
7.778 |
|
Debt/Equity ratio |
0.212 |
0.026 |
0.566 |
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Sales |
23.292 |
34.856 |
46.626 |
|
|
|
49.648 |
33.768 |
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Sales |
23.292 |
34.856 |
46.626 |
|
Profit |
2.621 |
5.641 |
3.715 |
|
|
11.25% |
16.18% |
7.97% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
Yes |
|
5 |
Buyer visit details |
Yes |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
Yes |
|
19 |
Major customers |
Yes |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
No |
|
22 |
Conduct of the banking account |
Yes |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
---------------------- |
|
28 |
Estimation for coming financial year |
Yes |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
---------------------- |
|
33 |
Market information |
---------------------- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
Trade References (along with address, contact details and name of
contact person)
|
Particulars |
Name of Contact
Person |
Contact Details |
|
Pfizer Products India Private Limited |
Sanjay Somsundaram |
91-22-66932370 |
|
Roche Products Private Limited |
Amit Trivedi |
91-22-33941414 |
|
Astellas Pharma Private Limited |
Sourav De |
91-22-61557676 |
|
Bristol Mysers Squibb India Private Limited |
Viraj Patil |
91-9930886225 |
OBSERVATION FORM
|
Company Name : |
Kartavya Healtheon Private Limited |
|
Address : |
514-519, Corporate Avenue, Sonawala Lane,
Goregaon (East), Mumbai – 400063, Maharashtra, India |
|
Contact No.: |
--- |
|
Email : |
--- |
|
Person To Whom We Met : |
Mr. Suraj |
|
Designation: |
Office Boy |
|
Name Board : |
Not Sighted |
|
Location : |
Easy |
|
Land Mark (If Any) : |
--- |
|
Total Floors Of The Building: |
09 |
|
Subject Situated On : |
5th Floor |
|
Locality : |
Commercial |
|
Area Of Premises : |
|
|
Area : |
Upmarket |
|
No. Of Employees Seen At Premises
: |
06 |
|
Visibility Of Items : |
|
|
Furniture Items Sighted : |
--- |
|
Sister Concerns (Other Names On Name Board) : |
--- |
|
Proof Of Visit: |
Photograph |
INDEX OF CHARGES
|
S. NO. |
CHARGE ID |
DATE OF CHARGE CREATION/MODIFICATION |
CHARGE AMOUNT SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST NUMBER (SRN) |
|
1 |
10452279 |
30/03/2015 * |
9,000,000.00 |
STATE BANK OF INDIA |
SMECCC, JASMINE CO-OP HOUSING SOCIETY, MADHUSUDAN, KALEKAR MARG, KALANAGAR, BANDRA EAST, MUMBAI - 400051, MAHARASHTRA, INDIA |
C49671423 |
* Date of charge modification
COMPUTATION
OF TOTAL INCOME
ASSESSMENT YEAR
2013-2014
(Rs. In Million)
|
Particulars |
Amount |
Amount |
Amount |
|
Income from Business |
|
|
|
|
Net Profit As per Profit and Loss Account |
7.522 |
|
|
|
Add : Depreciation As per Companies Act |
0.563 |
|
|
|
Add : Expenses Disallowed |
0.000 |
8.085 |
|
|
|
|
|
|
|
Less : Expenses Allowed |
0.000 |
|
|
|
Less : Depreciation As per Act |
0.302 |
|
|
|
Less : Income Exempted u/s 10 (34) |
0.000 |
0.303 |
|
|
|
|
|
7.782 |
|
Less : Brought forward loss of Past Years |
|
|
0.000 |
|
Total Income |
|
|
7.782 |
|
SELF-ASSESSMENT |
|||
|
a) Tax on above as per companies act |
|
|
2.334 |
|
b) Tax as per MAT u/s 115 / B |
|
|
0.000 |
|
|
|
|
|
|
Tax Payable whichever is higher (a) or (b) |
|
|
2.334 |
|
Add : Education Cess |
|
|
0.070 |
|
|
|
|
2.404 |
|
Less : TDS |
2.220 |
|
|
|
Less : Advance Tax |
0.000 |
|
2.220 |
|
|
|
|
0.184 |
|
Add : Interest u/s 234B |
|
|
0.011 |
|
Interest u/s 234c |
|
|
0.009 |
|
|
|
|
0.204 |
|
Less : Self-Assessment Tax paid u/s 140 A |
|
|
0.000 |
|
Payable/
(Refundable) |
|
|
0.204 |
PROJECTED
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2015 (Provisional) |
31.03.2016 |
31.03.2017 |
|
|
SALES |
|
|
|
|
|
Income |
139.110 |
160.503 |
177.755 |
|
|
Other Income |
0.000 |
0.000 |
0.000 |
|
|
TOTAL |
139.110 |
160.503 |
177.755 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Operative Expenses |
83.390 |
86.453 |
88.196 |
|
|
Employees benefits
expense |
23.946 |
34.338 |
37.772 |
|
|
Other expenses |
20.498 |
21.502 |
23.652 |
|
|
TOTAL |
127.834 |
142.293 |
149.620 |
|
|
|
|
|
|
|
Less |
PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND
AMORTISATION |
11.276 |
18.210 |
28.135 |
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES |
3.737 |
5.255 |
5.257 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
TAX, DEPRECIATION AND AMORTISATION |
7.539 |
12.955 |
22.878 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
0.607 |
0.596 |
0.626 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE TAX |
6.932 |
12.359 |
22.252 |
|
|
|
|
|
|
|
Less |
TAX |
1.733 |
3.090 |
5.563 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) AFTER TAX
|
5.199 |
9.269 |
16.689 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (Rs.) |
456.05 |
5.78 |
9.39 |
NET
WORTH STATEMENT
Mr.
ANIL NAYAK
STATEMENT OF
ASSETS AND LIABILITIES AS ON 03RD MARCH 2015
(Rs. In Million)
|
LIQUID ASSETS
LIFE INSURANCE
POLICIES:
JEWELLERY: INVESTMENT IN
BUSINESS IN ASSOCIATE FIRM, IF ANY:
INCOME PER MONTH : Rs. 0.100 Million LIABILITIES PARTICULARS: BORROWINGS FROM BANKS: NOT APPLICABLE
BORROWINGS FROM MARKET: NOT APPLICABLE BORROWINGS FROM OTHER SOURCES: NOT APPLICABLE ASSUMED INDIRECT LIABILITY: NOT APPLICABLE |
BIKRAM BINAY SRIVASTAVA
STATEMENT OF
ASSETS AND LIABILITIES AS ON 03RD MARCH 2015
(Rs. In Million)
|
LIQUID ASSETS
LIFE INSURANCE
POLICIES :
JEWELLERY : Rs.1.000 Million INVESTMENT IN
BUSINESS IN ASSOCIATE FIRM, IF ANY:
INCOME PER MONTH : Rs. 0.100 Million LIABILITIES PARTICULARS: BORROWINGS FROM BANKS: NOT APPLICABLE
BORROWINGS FROM MARKET: NOT APPLICABLE BORROWINGS FROM OTHER SOURCES: NOT APPLICABLE ASSUMED INDIRECT LIABILITY: NOT APPLICABLE |
COMPANY
PROFILE
|
MILESTONES 2008: Launch of disease management company in June 2008 2009: Kartavya Spreads its operations via field force in 3 cities 2010: Evolution of more patient programs in new therapeutic areas 2011: - Disease screenings for Hep B across 16 cities in India - Tie-ups with leading Diagnostic Labs for specialized test 2012: - Operations in 24 cities - Launches Supply chain and distribution of medicines across India - Launches EMI options for medicine purchase 2013: - Tie up with dietitians and physiotherapist 30+ cities - Pan India Coverage of Lab technician for sample pickup 2014: - Launches home based care - Doctor Mobile Apps launched - Cold Chain Product distribution - Setting up of Centralized Reference Lab in Mumbai - New distribution center KARTAVYA–AT A
GLANCE People - 120+ people - Support in 12 language - In house training team Compliance - ISO 9001:2008 certification - Audit readiness in 5 days\ - Physical and cloud data storage services IT - Work Class Dedicated IT services -
ISO27001 -2005 ISMS certification Process and
Programs - Running currently 24 Patient Programs across various therapeutic areas - Managing a patient pool of 70000+ across India |
ANIL
NAYAK’S PROFILE
|
Mr. Anil Nayak Director and Co-Founder Kartavya Healtheon has worked closely with pharmaceutical companies as a software consultant and enjoys a decade long experience in managing operations in IT sector. With his professional strengths and business acumen intact, Anil went on to co-found found Kartavya Healtheon in 2008. As the director and promoter, he is responsible for laying out growth plans and operational strategies for the company. Anil also plays a key role in assessing marketing opportunities and target markets, analyzing economic trends, government policies and newer technologies to bring in innovation in Kartavya’s patient support programs and introducing value added services like pathology services and home based care services to patients enrolled on various programs through its subsidiary arms. Anil, with his robust understanding of the sector, develops the SWOT (Strength, Weakness, Opportunity and Threat) analysis for the company to determine the strategic plan for the future. Anil holds AMIE Sec A - Diploma in Computer Engineering and PGDAC (Pune, CDAC). He also cofounded Plus LabSnyc a pathology lab chain in 2014 and has distinct expertise in operations, Technology, client acquisition, strategic planning and process innovation. |
BIKRAM BINAY SRIVASTAVA’S PROFILE
|
Mr. Bikram Binay Srivastava, Director and Co-Founder of Kartavya Healtheon, is a visionary entrepreneur with a mission to upgrade life standards of patients suffering from chronic diseases by providing care and support. Bikram established Kartavya Healtheon in 2008 to provide disease and patient management services. The company improves the quality of patient services through innovative and efficient technology & communication platforms. Earlier he worked has a software consultant with more than 10 years of experience in managing business development and managing key customer accounts for business solutions. Bikram holds PGDBM in Systems and Bachelor of General Law (BGL) from Mumbai University. He also has AMIE Sec A – Diploma in Computer Engineering. Bikram has cofounded Plus LabSnyc a pathology lab chain in 2014 and holds expertise in client servicing, strategizing new delivery models, business development, corporate communications and legal arrangements. |
FIXED ASSETS
- Air
Conditioner
- Telephone
- Furniture and
Fixtures
- Office
Equipment
- Printer
- Mobile
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.38 |
|
|
1 |
Rs.99.13 |
|
Euro |
1 |
Rs.69.68 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRT |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
PNM |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILITY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER
|
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
46 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.